Yuhan Corp.’s Second-Quarter Operating Profit Rises 595.8% From Previous Quarter to 61.4 Billion Won

Ionkura Reports 20.8-Month Median Survival in Phase 1 Trial for Metastatic Eye Cancer

Verastem’s VS-7375 Shows Response Rates of Up to 50% in Pancreatic Cancer; Phase 3 Trial to Begin This Year

Pfizer to Co-Develop Sec61 Inhibitors With Enodia in Deal Worth Up to $500 Million

Galderma to Acquire ZO Skin Health for $1.5 Billion, Expanding Dermatology Portfolio

Verdiva halts GLP-1 transition trial, citing ‘market changes’

Stryker to Invest $400 Million in CMR Surgical, Expand Robotic Surgery